Apria CEO: ‘2021 was a banner year’
By HME News Staff
Updated 11:36 AM CST, Mon February 28, 2022
INDIANAPOLIS – Apria Healthcare has reported net revenue of $296.5 million for the fourth quarter of 2021, up 0.9% compared to the same period in 2020. Net income was $17 million vs. $25.9 million, down 34.5%.
The company reported net revenue of $1.15 billion for the full year 2021, up 3.3% compared to full year 2020. Net income was $64.9 million vs. $46.1 million, up 40.6%.
“We reported solid fourth quarter financial results and 2021 was a good year for Apria,” said Dan Starck, CEO. “Our team did an excellent job operating and executing at a high level while navigating the challenges from the COVID-19 pandemic, as well as a major product recall and supply chain constraints. Fourth quarter revenue and Adjusted EBITDA were at the high end of our guidance ranges, while Adjusted EBITDA less Patient Equipment Capex was in-line with our expectations. During the fourth quarter, we continued to be impacted by the Philips recall and the supply chain disruption which slowed new sleep patient starts and new ventilation patient starts in the quarter. That said, we continue to see strong demand for CPAP and ventilation, and we expect demand will remain strong for the foreseeable future. Overall, 2021 was a banner year for Apria despite the COVID pandemic and supply chain constraints. I am proud of what we accomplished together in 2021.”
Apria reported adjusted EBITDA of $58.4 million for the fourth quarter of 2021, down 8.8% compared to the same period in 2020. It reported adjusted EBITDA of $232 million for the full year 2021, up 2.3%.
Comments